MMSI
Merit Medical Systems Inc.
$64.48
+$0.31(+0.48%)
50
Overall
60
Value
18
Tech
73
Quality
Market Cap
$6.12B
Volume
490.22K
52W Range
$59.74 - $97.18
Target Price
$90.64
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $603.8M | $727.9M | $882.8M | $994.9M | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | ||
| Total Revenue | $603.8M | $727.9M | $882.8M | $994.9M | $963.9M | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $338.8M | $401.6M | $488.0M | $562.5M | $562.7M | $589.4M | $631.9M | $673.5M | $713.2M | $777.6M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $265.0M | $326.3M | $394.8M | $432.4M | $401.2M | $485.3M | $519.1M | $583.9M | $643.3M | $738.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $230.1M | $293.2M | $336.2M | $416.9M | $402.7M | $424.4M | $431.5M | $459.9M | $487.6M | $553.5M | ||
| Research & Development | $45.7M | $63.5M | $60.2M | $66.1M | $57.8M | $71.2M | $82.2M | $84.3M | $87.5M | $97.4M | ||
| Research Expense | $45.2M | $51.4M | $59.5M | $65.6M | $57.5M | $71.2M | $75.5M | $82.7M | $87.5M | $97.4M | ||
| Selling, General & Administrative | $184.4M | $229.1M | $276.0M | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | $455.2M | ||
| General & Administrative Expenses | $184.4M | $229.1M | $276.0M | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | $455.2M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $34.9M | $33.1M | $58.6M | $15.4M | $-1.6M | $60.9M | $87.6M | $123.9M | $155.7M | $184.7M | ||
| EBITDA | $78.9M | $97.9M | $130.2M | $119.7M | $104.2M | $155.6M | $181.8M | $228.9M | $295.9M | $332.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $8.8M | $7.7M | $10.4M | $12.4M | $10.0M | $5.3M | $6.3M | $15.5M | $31.2M | $26.5M | ||
| Intinc | $81.0K | $381.0K | $1.2M | -- | -- | -- | -- | -- | $26.2M | -- | ||
| Net Non-Operating Interest Income/Expense | $-8.7M | $-7.4M | $-10.4M | $-12.4M | $-10.0M | $-5.3M | $-6.3M | $-15.5M | $-31.2M | $-26.5M | ||
| Gain on Sale of Securities | -- | -- | $1.2M | $-291.0K | $604.0K | $769.0K | $439.0K | $2.5M | $26.2M | $15.1M | ||
| Other Income/Expense | $773.0K | $-10.2M | $-1.3M | $828.0K | $1.7M | $1.7M | $-1.4M | $-3.7M | $-25.5M | $-12.7M | ||
| Other Special Charges | $-773.0K | $-872.0K | $63.0K | $-537.0K | $-2.3M | $-2.5M | $966.0K | $1.2M | $-711.0K | $-2.4M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | $-809.0K | $-657.0K | $-23.8M | $-55.2M | $-14.3M | $-2.2M | $-270.0K | -- | -- | ||
| Impairment of Capital Assets | -- | $809.0K | $657.0K | $23.8M | $36.5M | $4.3M | $2.2M | $270.0K | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $34.2M | $43.6M | $59.9M | $14.6M | $-3.2M | $59.2M | $89.0M | $127.6M | $181.2M | $197.4M | ||
| Pre-Tax Income | $25.4M | $35.9M | $49.5M | $2.2M | $-13.2M | $53.9M | $82.6M | $112.1M | $150.0M | $170.9M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $5.3M | $8.4M | $7.5M | $-3.3M | $-3.4M | $5.5M | $8.1M | $17.7M | $29.6M | $42.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $20.1M | $27.5M | $42.0M | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M | ||
| Net Income (Continuing Operations) | $20.1M | $27.5M | $42.0M | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M | ||
| Net Income (Discontinued Operations) | $20.1M | $27.5M | $42.0M | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M | ||
| Net Income (Common Stockholders) | $20.1M | $27.5M | $42.0M | $5.5M | $-9.8M | $48.5M | $74.5M | $94.4M | $120.4M | $128.5M | ||
| Normalized Income | $16.5M | $13.1M | $39.8M | $22.7M | $38.6M | $56.9M | $67.5M | -- | -- | $169.2M | ||
| TOTALS | ||||||||||||
| Total Expenses | $569.0M | $694.8M | $824.1M | $979.4M | $965.4M | $1.0B | $1.1B | $1.1B | $1.2B | $1.3B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $44.4M | $48.8M | $52.3M | $55.1M | $55.4M | $56.1M | $56.8M | $57.6M | $58.2M | $59.2M | ||
| Average Shares Outstanding (Diluted) | $44.9M | $50.1M | $53.9M | $56.2M | $55.4M | $57.4M | $57.7M | $58.4M | $59.4M | $60.5M | ||
| Shares Outstanding | $44.7M | $50.3M | $54.9M | $55.2M | $55.7M | $56.6M | $57.3M | $57.9M | $58.8M | $59.4M | ||
| Basic EPS | $0.45 | $0.56 | $0.80 | $0.10 | $-0.18 | $0.86 | $1.31 | $1.64 | $2.07 | $2.17 | ||
| Basic EPS (Continuing Operations) | $0.45 | $0.56 | $0.80 | $0.10 | $-0.18 | $0.86 | $1.31 | $1.64 | $2.07 | $2.17 | ||
| Diluted EPS | $0.45 | $0.55 | $0.78 | $0.10 | $-0.18 | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 | ||
| Diluted EPS (Continuing Operations) | $0.45 | $0.55 | $0.78 | $0.10 | $-0.18 | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 | ||
| OTHER METRICS | ||||||||||||
| Development Expense | $461.0K | $12.1M | $644.0K | $525.0K | $250.0K | -- | $6.7M | $1.6M | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | $18.7M | $10.0M | -- | -- | -- | -- | ||
| Other Gand A | $184.4M | $229.1M | $276.0M | $327.3M | $297.7M | $335.7M | $342.5M | $373.7M | $399.7M | $455.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MMSI | $64.48 | +0.5% | 490.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Merit Medical Systems Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW